| Tag | Content |
|---|
EnhancerAtlas ID | HS139-26476 |
Organism | Homo sapiens |
Tissue/cell | Myotube |
Coordinate | chr19:19716630-19717590 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| NFIC | MA0161.2 | chr19:19716893-19716904 | TACTTGGCAGA | + | 6.62 | | Nr2f6(var.2) | MA0728.1 | chr19:19717571-19717586 | GAGGTCAGGAGTTCA | + | 6.22 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_12109 | chr19:19716466-19717674 | CD3 | | SE_18839 | chr19:19716269-19719196 | CD4p_CD25-_Il17-_PMAstim_Th |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH19I019605 | chr19 | 19716281 | 19718317 |
|
Enhancer Sequence | TTCTGTAAAG GCTCTAGGAT TTTTTTTTTT TTTTTTTTTT TTACCAGTTT TCTCCTTATA 60
AAATATTTTA CTTTAGATAC AGTAGAAAGC ACTTTTTAAT GCATACAAAG TAATTTCATA 120
GTTTCTGTGG CTTACTATGA AAAGAAAACA AGTTCCCAAG CTTTGAGCAT GTCTTTGAGC 180
TAGCAGTGAT CAAGCAGCTG CTGCAAATCA GTGAGGAAAA GGGGACTGAC TAGTGAGACC 240
TTCCCCAAGG GGATGAAATC ACTTACTTGG CAGACACACC CTAAGGTAAC CCCCAGTGAG 300
TCATGTCCTT ATATAATCCT TTTTCCTTGA GTTCAGGAAG TACCTGTGAC TTGCAATGTG 360
CCAAAGGTGA TGGTATCATC TCTGCCATGG TTATGTTGTT ATCTAAGACT CCACCTTAGA 420
TGACTAGAGA GTCACCCACT GGCACCAGCT GCCATGTCAT GACAGCTGGT GGCAGGAACT 480
GCAGGCAGCC TCTAAAGCTG AGAGCAGCCT CAACTGACAG CCAGGAAGAA AGCAGGGACC 540
TTTGTGCTTC AACTGCAGGA AGTGAATTCT TCCATCAACC ATGCGACACT GGGAGAGAAC 600
CCCATGCTCT GGATAGGAAC ATAGCCCAGC CAACACCTTG ACTGCAGCCC TGTGAGACCC 660
TAAGCAGAGG ACCTAGCTAA GCTGTGCCCA GAATCCTGAC CCAAGGAAAC TGTGAGATAA 720
TAAATATCTG CTGTTTTAAG CTGCTAGGCT TGCGGTGATT TCTTATAAAG CAATAGAGAG 780
TTGATAATGA GATAGACTGG AAGCCAGAGA ATGGGGACCG TTGGGAGAAA AATGGGGTTG 840
GTGCTGGTAT GTCTAACAAG TATATGACAC GTTATGGCTG GGTGCCGTGG CTCATGCCCG 900
TAATCCCAGC ACTTTGGGAG GCTGAAGCGG GCGGATCACC TGAGGTCAGG AGTTCAAAAC 960
|
